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Abstract 
 
Attention Deficit Hyperactivity Disorder: An exploratory analysis of treatment preferences 
Margaret Howley 
 
Attention Deficit Hyperactivity Disorder is a chronic and pervasive disorder. Medication 
as well as psychosocial treatment has proven effective in managing the symptoms of ADHD in 
children.  Research has found that the symptoms of hyperactivity and impulsivity decrease with 
age while the symptoms of inattention stay stable over time. The current analysis will consider 
whether treatment for ADHD is concurrent with this trend in symptom presentation as well as 
whether gender plays a role in treatment utilization. It is hypothesized that children diagnosed 
with ADHD combined type will receive more treatment with medication than psychosocial 
treatment and treatment overall will decrease with age in accordance with the waning of 
hyperactive symptoms.  It is also hypothesized that children diagnosed with ADHD inattentive 
type will receive more psychosocial treatment than treatment with medication, as their symptoms 
are not as externalizing and disruptive. However, the use of treatment (medication and 
psychosocial) will increase with age as the symptoms of Inattention become more apparent. The 
analysis will also consider differences in medication use in terms of gender.  
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CHAPTER 1: BACKGROUND AND LITERATURE SURVEY 
 
1.1 General  
 
Attention-deficit hyperactivity disorder (ADHD) is a chronic and pervasive disorder typically 
presenting in early childhood.  The symptoms generally include inattentiveness, distractibility, 
impulsiveness and impairments in executive functioning that are functionally significant.  
Symptoms also may include increased behavioral and verbal impulsivity and hyperactivity.  It is 
estimated that the prevalence rate of ADHD is between 3% and 7% (Diagnostic and Statistical 
Manual of Mental Disorders). 
 Weiss and Hechtman (1993), found that the interpersonal problems associated with 
ADHD persist into adulthood in 75% of children diagnosed.  Furthermore, juvenile problems and 
antisocial personality may occur in 23% to 45% of children (Barkley et al., 2004) and 20-27% of 
children may have substance use disorders (Fischer, Barkley, Smallish, & Flethcer, 2002).   
 
1.2 Symptoms 
 
Children diagnosed with ADHD display symptoms of inattention relative to matched 
controls.  Inattentiveness has been found to result from a lack of persistence of effort.  Children 
diagnosed with ADHD display difficulties in sustaining effort in tasks with minimal appeal or 
little immediate consequences (Barkley, 1997).   As a result, these children are drawn toward 
activities with more immediate rewards. Children diagnosed with ADHD therefore, shift their 
task more than a child without a diagnosis of ADHD (Barkley, 1997).   
 Impulsiveness is another symptom of ADHD that is associated with a deficiency in 
inhibiting behavior when appropriate.  Children diagnosed with ADHD displaying impulsive 
behavior typically jump into activities quickly and fail to consider the consequences of their 
actions (Barkley, 1998).  When presented with a task that involves working toward a larger goal 
and delayed gratification, the child will typically opt for a situation with a smaller reward and 
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immediate gratification due to a lack of consideration for the consequences of their actions 
(Barkley, 1998). 
 Hyperactivity is another symptom of ADHD.  This refers to excessive levels of activity 
that are developmentally inappropriate.  While working on tasks at school these children 
diagnosed with ADHD typically are out of their seat, restlessly moving their arms and legs, 
playing with objects with no relation to the task and talking out of turn (Fischer, Barkely, 
Edelbrock, 1990).  The symptoms of hyperactivity are significantly more apparent than in 
children of equivalent age without a diagnosis of ADHD (Barkley, 1998). 
 There are currently three subtypes that further define a diagnosis of ADHD.  Attention 
Deficit Hyperactivity Disorder hyperactive/impulsive subtype refers to children that dominantly 
display hyperactive and impulsive symptoms.  Similarly, ADHD inattentive subtype refers to 
children that dominantly display inattentive symptoms.  Lastly, ADHD combined type refers to 
children that display both inattentive and hyperactive symptoms at a clinically significant rate.  
 For a child to receive a diagnosis of ADHD, functional impairment must be present in at 
least two settings.  These settings may include, school, work, home or any other activities in 
which the child may engage.  The child must also display clinically significant impairment in 
social, academic or occupational functioning.    
 
1.3 Gender  
 
Research has shown that the prevalence of Attention Deficit Hyperactivity Disorder is 
much higher among males than females although the exact proportion varies somewhat across 
studies.  Gadow, Sprafkin, & Nolan (2001), found the prevalence rates to be 4% in girls and 8% 
in boys in the preschool age group.  While in the 6-12-year-old age period rates have been found 
to range from 2-4% in females and 6-9% in males (Breton et al., 1999).   At the Children’s 
Hospital of Philadelphia Center for the Management of ADHD, where the data for the current 
analysis was collected, the ratio of males to females diagnosed with ADHD is 3 to 1.   
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 There is also evidence that males with ADHD display different symptoms than females 
diagnosed with ADHD.  Abikoff and colleagues (2002), found that girls with ADHD tend to 
show less severe symptoms of inattention and hyperactive-impulsive behavior, especially in 
school.  Brown, Abramowitz, Dadan-Swain, Eckstrand, & Dulcan (1989) studied clinic referred 
children and found that females are more socially withdrawn and exhibit more internalizing 
symptoms than males. Berry, Shaywitz, & Shawitz (1985), found that hyperactive females had 
lower verbal IQ scores, had more problems with mood, and were more likely to have language 
disability. Barkley (1998) found that the most reliable difference between males and females is 
that males diagnosed with ADHD are more likely to develop Oppositional Defiant Disorder and 
Conduct Disorder.   
 
1.4 Age 
 
 ADHD is a chronic condition that is pervasive through childhood, adolescence and 
adulthood.  However, Hart, Lahey, Loeber, Applegate & Frick (1995) found that the symptoms of 
hyperactivity and impulsivity decrease with age while inattentive symptoms stay stable.  
Participants included one hundred six clinic-referred boys diagnosed with ADHD.  The annual 
assessments were conducted for 4 years.  The results of the study found that inattention declined 
from the first to second assessment and then remained stable while hyperactivity and impulsivity 
symptoms decreased consistently with age.    Although symptoms of ADHD decrease with age, 
research has shown the symptoms do not normalize (Biederman, Faraone, Taylor, Sienna, 
Williamson & Fine, 1998).  The current investigation will consider the difference in the type of 
treatment utilized in terms of age.  Three age groups will be considered: Three - 5 years old, 6 – 8 
years old and 9 – 11 years old.  The analysis considered the choice to utilize medication in 
conjunction with psychosocial treatment verse solely utilizing psychosocial treatment between the 
age groups. 
 
1.5 Treatment 
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1.5.1 Medication 
 
Froehlich, Lanphear, Epstein, Barbaresi, Katusic and Kahn (2007), considered 3,082 
children and found that less then half of the children meeting the criteria for ADHD reported 
receiving regular treatment. 
The most commonly prescribed medication for children with ADHD is Central Nervous 
System stimulants.  CNS stimulants raise the level of activity, arousal, or alertness of the Central 
Nervous System (DuPaul, Barkley & Connor 1998).  Safer, Zito & Fine (1996) estimated that 
annually, 1.5 million children of school-aged population may be using stimulant medication for 
behavior management. The three most common types of stimulant medication are: 
Methylphenidate (Ritalin), Adderall, dextroamphetamine and Concerta.  More recently, stimulant 
medication has become available in extended-release forms, lasting up to 12 hours.   Once-daily 
stimulants have become increasingly popular in the treatment of ADHD as the sustained effects 
are ideal for a full day of school (Mash & Barkley, 2006).   
 Research has shown stimulant medication to be effective for many children with a 
diagnosis of ADHD.  Behavioral improvements produced by stimulants include sustained 
attention, reduction of task irrelevant activity and improved impulse control, particularly in 
settings requiring behavioral restraint (Solanto et al., 2001).  Furthermore, both overt and covert 
aggression has been shown to decrease in children taking stimulant medication (Connor, Glatt, 
Lopez, Jackson, & Melloni, 2002).  Barkley (1977) reviewed more than 120 studies and found 
between 73% and 77% of children treated with stimulant medication were considered to show 
improvement in their behavior.  DuPaul & Rappaport (1993) looked at thirty-one children 
diagnosed with Attention Deficit/Hyperactivity Disorder.  They found that 75% of the children 
displayed improvement to the point of no longer statistically deviating from the behavior of 
control children without ADHD.  Safer, Zito & Fine (1996) found a consistent improvement in 
academic and social functioning in about 50% to 90% of children when taking stimulant 
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medication.  Another study found significant increases in scores on an IQ test when children 
diagnosed with ADHD were taking stimulant medication (Gimpel, et al. 2005).   Vitiello and 
colleagues (2007) considered the effectiveness of methylphenidate in preschoolers when utilized 
over a 10-month period.  Ninety-five children completed the 10-month treatment.  The results 
revealed that with careful monitoring and gradual increases in dosage the preschoolers’ behavior 
improved (Vitiello, et al. 2007).  
 Stimulant medication is effective in treating many children diagnosed with ADHD but it 
has been shown that 20% to 30% of children put on stimulants may not display any behavioral 
change.  In some cases behavior may, in fact, worsen in response to medication (DuPaul, Barkley 
& Connor, 1998).  Elia & Rappaport (1991) found that children whose symptoms are not 
controlled by a certain type of stimulant medication may respond more favorably to another 
stimulant medication and found that close to 90% of children eventually respond to medication if 
they tray another after finding one to be ineffective.  Johnston, Pelham, Hoza & Sturges (1988) 
found that of 21 children, about a third displayed a deterioration of behavior (beyond baseline) in 
the evening after receiving stimulant medication during the day.  Furthermore, Richters, and 
colleagues (1995) suggest that stimulant medication provides dramatic short-term effects on the 
core clinical symptoms of ADHD but has been less reliable in bringing about long term 
improvement.  
 A fourteen-month MTA study considered 579 children between the ages of seven years 
old and nine years old that had been diagnosed with ADHD.  The study included four treatment 
groups: Behavioral Treatment, Medication Management, Combined Behavioral Treatment and 
Medication Management and a control group.  The researchers concluded that supervised 
Medication Management was the most effective in treating children diagnosed with ADHD 
(MTA Group, 1999). 
 Strattera is a non-stimulant medication approved in 2003 for the use in treating ADHD in 
children 6 years of age and older.  The effectiveness of Straterra has been established in over 10 
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large scale randomized controlled clinical trials.  The samples included 3,264 children and 
adolescents, and 471 adults (Kratochvil etal., 2001, Michelson et al., 2003, Spencer et al., 1998).  
These clinical trials found Straterra to be effective as well as safe in the treatment of ADHD.  
Research has found that Straterra reduces the symptoms of inattention and hyperactivity-
impulsivity in over 70% of cases (Michelson, et al. 2001).   
 
1.5.2 Psychosocial Treatment 
Psychosocial approaches have been utilized in the treatment of ADHD as well.  Family-
based interventions have been found to be effective in treating children with ADHD.  Family-
based treatment provides parents with instructions in implementation of behavior modification 
techniques that typically revolve around social learning principles.  The theory behind this type of 
treatment is that parent training will lead to a change in parenting style which will in turn treat a 
child’s ADHD symptoms (Chronis, Jones, Raggi, 2006).  Anastopolous, Shelton, DuPaul, & 
Guevermont (1993) found that parent training also improves parental reports of stress, which in 
turn may lead to more effective treatment of the child’s ADHD symptoms by the parent.  Pelham 
et al. (1988) found that parent training led to improvements in the child’s social behavior as well 
as social acceptance.  The literature reveals that parent training is a valuable way of treating the 
stymptoms of ADHD.   
 Another approach to treating children diagnosed with ADHD is to use a school-based 
intervention.  Similar to parent training, teachers are educated in the use of behavior modification 
techniques.  Teachers are taught techniques such as praise, planned ignoring, effective 
commands, time out and the use of daily report cards (Pelham, Wheeler, & Chronis, 1998).  The 
daily report card is an important aspect of school-based intervention as goals are set and the child 
is rewarded at home if the goals are met.  The goals and reinforcement are tailored to the child’s 
specific developmental level (Pelham, 2002).   Dupaul & Eckert (1997) conducted a meta-
analysis of the research literature on school interventions for ADHD.  Seventy separate 
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experiments were utilized.  The researchers found an overall effect size for contingency 
management procedures of .60 for between-subject designs, 1.00 for within-subject designs and 
about 1.40 for single-case designs  They also found that interventions aimed at improving 
academic performance by manipulating the curriculum for children with ADHD produced equal 
or greater effect sizes.   
 Social skills training is also an intervention that has been utilized in treating children 
diagnosed with ADHD.  Peer relationships tend to be an area in which children with ADHD 
struggle and are therefore an important target for treatment (Melnick & Hinshaw, 1995).  This 
type of treatment requires that children be taught social skills appropriate to their behavioral 
level.  The treatment includes the reinforcement of skills such as communication, cooperation, 
participation and validation (Kavale, Forness, & Walker, 1999).   
 The summer treatment program is an intensive 8-week outpatient program for children 
diagnosed with ADHD.  The treatment includes weekly, group-based parent training, a point 
system for children, positive reinforcement, effective commands, time out, a daily report card, 
social skills training, sports skills training and problem solving techniques (Chronis et al., 2004).  
The treatments are utilized across academic as well as recreational settings throughout the course 
of each day.  The goal of the treatment is to improve children’s peer relationships, interactions 
with adults, academic performance, and self-efficacy (Chronis et al., 2004).  The summer 
treatment program has been found to be an effective intervention program when compared to a 
camp setting without any behavior modification strategies employed (Chronis, et al., 2004).     
There has been evidence suggesting that a multimodal approach to the treatment of 
ADHD may be more effective than utilizing one type of treatment in isolation.  In considering 
this, So, Leung and Hung (2008) considered 90 Chinese children diagnosed with ADHD.   There 
were two treatment conditions: methylphenidate-only and methylphenidate with Behavior 
Therapy.  The researchers found that a low dose of methylphenidate in combination with 
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Behavior Therapy were significantly more effective than just methylphenidate.  At 6 and 12-
month follow ups, the improvement in behavior remained stable.   
The MTA study found that a multimodal approach to treatment was more effective in 
treating ADHD with comorbid anxiety disorders, children of low socioeconomic status and 
ethnically-diverse children (MTA Cooperative Group, 1999).  However, combined treatment was 
more effective than medication alone with many of the social targets of treatment such as 
improved social skill and parent-child relationships (Hinshaw et al., 2000).  Furthermore, a 
secondary analysis revealed that combined treatment was more effective in normalizing behavior 
and allowed for a lower dose of medication to be utilized (MTA Cooperative Group, 1999).   
Swanson and colleagues (2001) created a categorical measure of treatment outcome based on 
scores from teachers and parents that completed the Swanson, Nolan, and Pelham Quesionnaire – 
IV.  They found that treatment success rates were as follows: 68% for combined treatment, 56% 
for Medication alone and 34% for behavioral treatment alone.    
 
CHAPTER 2: OBJECTIVE AND HYPOTHESES 
 
2.1 Objective 
 The current study was an exploratory analysis using an archival data set to consider 
whether subtype, age and gender contribute to a lack of treatment as well as treatment utilization 
in children between the ages of 5 and 13 years. 
 
2.2 Hypotheses 
2.2.1 Primary Hypothesis  
Children diagnosed with ADHD combined type will receive more treatment with 
medication than psychosocial treatment and treatment will decrease with age in accordance with 
the waning of hyperactive symptoms.  Children diagnosed with ADHD inattentive type will 
receive more psychosocial treatment than treatment with medication, as their symptoms are not as 
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externalizing and disruptive.  However, it is hypothesized that the use of treatment (medication 
and psychosocial treatment) will increase with age as the symptoms of Inattention become more 
apparent.  
2.2.2 Secondary Hypothesis 
 Males will receive more treatment overall with medication verse females diagnosed with 
Attention Deficit Hyperactivity Disorder.  Males with combined subtype will receive treatment 
the most frequently.   
 
CHAPTER 3: METHOD 
 
 
 
3.1 Participants 
 
The data set originally collected at the Children’s Hospital of Philadelphia includes 1.005 
children.  Participants were included in the previously collected data set if they were not 
intellectually disabled or had a Developmental Disorder and were deemed to possibly have a 
diagnosis of ADHD upon preliminary intake.  The initial screening process included an intake 
conducted by phone.  The family was contacted, informed about the services provided and asked 
questions about their child’s behavior.  If the clinician determined the child may be eligible 
(behavior suggested a diagnosis of ADHD without a comorbid Developmental Disorder), 
measures were sent to the parent and teacher to complete concerning the child.  The measures 
sent to and completed by the parent included: The Pediatric Developmental Questionnaire, The 
Behavior Assessment System for Children parent version, the Homework Problem Checklist and 
the ADHD Rating Scale-IV parent version.  The Behavior Assessment for Children teacher 
version, ADHD Rating Scale-IV and Academic Performance Questionnaire were mailed to the 
teacher for completion concerning the child.  The measures were then reviewed by the clinician.   
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The current analysis included 433 participants.  Participants from the original data set were not 
utilized if they were not between the ages of 5 and 13 years old and if they did not meet the 
criteria for ADHD Inattentive type, ADHD combined type or no diagnosis of ADHD. The criteria 
for diagnosing ADHD inattentive subtype were the parent report on the DICA-R-P met criteria 
for ADHD inattentive type and ratings on the ADHD Rating Scale-IV Teacher Version were at or 
above the 85th percentile on the Inattentive factors.  The criteria for diagnosing ADHD combined 
subtype were a parent report on the DICA-R-P met criteria for ADHD hyperactivity/impulsivity 
as well as inattention and ratings on the ADHD Rating Scale-IV Teacher Version were at or 
above the 85th percentile on both the hyperactivity/impulsivity factors and the inattentive factors.     
 The participants were determined to not have a diagnosis of ADHD if they did not meet 
DICA-R-P criteria for any ADHD subtype, and were not at or above the 85th percentile on the 
ADHD Rating Scales.   
 
3.1.1 Inclusion Criteria 
 
 A preliminary screening was conducted on potential participants.  Participants were 
included if the initial judgment of the clinician was that the child may have a diagnosis of ADHD.   
For the purposes of the current analysis, participants were included if their chronological age is 
between 5 and 13 years.   
 
 
3.2 Diagnostic Measures 
 
In the original study, each participant was required to have a parent and teacher fill out a number 
of measures.  The measures utilized in the current study are as follows. 
 
3.2.1 Diagnostic Interview for Children and Adolescents- Revised- Parent Version 
 
 The DICA-R (Reich, Leacock & Shankefeld, 1995), is a semi-structured diagnostic 
interview.  It is designed using the symptoms from the DSM-IV and is utilized to evaluate 
childhood psychopathology.  Estimates of inter-rater reliability of the DICA-R-P have continually 
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been above the acceptable reliability range (Eiraldi, Power, Karustis, & Goldstein, 2000).  Also, 
Reich (2000) studied a sample of 40 children aged six to twelve and thirty-five adolescents and 
found both groups displayed acceptable Kappa levels in reliability.    
 In the data set, doctoral level psychologists and advanced doctoral students in psychology 
administered the DICA-R-P.  All psychologists and students were required to undergo training in 
the administration of the DICA-R-P.  The interviews were video taped and a number were 
randomly chosen to be rated by another trained clinician to determine inter-rater reliability.   
Inter-rater reliability scores were obtained for 20% of the cases in the sample.  The DICA-R 
contains scales that assess for the presence of a number of mental disorders.  For the purposes of 
the current analysis, the section of the DICA-R  pertaining to ADHD was considered as it 
distinguished hyperactive and inattentive symptoms and was a key part of the diagnostic criteria 
utilized in determining a participant’s diagnosis.     
 
3.2.2 ADHD Rating Scale-IV-Teacher Version 
 
 The ADHD Rating Scale-IV (Dupaul, Power, Anastopoulos, & Reid, 1998) is adapted 
from the DSM-IV symptom list of ADHD.  It contains eighteen items: Nine inattentive items and 
nine hyperactive items.  The measure lists classroom behaviors typical of children with ADHD 
and asks the teacher to rate on a Likert Scale (0-4) the frequency of each behavior.  Estimates of 
test-retest reliability, internal consistency and concurrent validity support the integrity of the 
measure (DuPaul, Power, Anastopoulos, & Reid,1998).  In the data set, the 85th percentile cutoff 
was used to assist in the diagnosis of the subtype of ADHD due to its efficacy in identifying 
subtypes when used in conjunction with a parent measure (Power et al. 1998).      
 
3.2.3 ADHD Rating Scale-IV-Parent Version 
  
   The ADHD Rating Scale-IV- Parent Version (Dupaul, Power, Anastopoulos, & Reid, 
1998) is adapted from the DSM-IV symptom list of ADHD.  It consists of eighteen items, nine of 
which are inattentive symptoms and nine hyperactive symptoms.  The measure lists behavior at 
Tx Utilization ADHD 12    
 
home that is typical of children with ADHD and asks a parent to rate (from 0 – 4) how frequently 
the behavior is exhibited.   
 
3.2.4 Behavior Assessment System for Children and Adolescents – Parent Rating Scale 
 
 The Behavior Assessment System for Children – Parent Rating Scale (Reynolds & 
Kamphaus, 1992) was designed to assist in evaluating children’s emotional and behavioral 
functioning at home.  The BASC-PRS has three different versions that take into account the 
different developmental issues between age groups.  There is a preschool version (2-5 years old), 
child version (6-11 years old) and an adolescent version (12-18 years old). 
 
3.2.5 Behavior Assessment System for Children and Adolescents –Teacher Rating Scale 
 
 The Behavior Assessment System for Children – Teacher Rating Scale (Reynolds & 
Kamphause, 1992) was designed to assist in evaluating children’s emotional and behavioral 
functioning at school.  It asks questions about common behaviors seen in the classroom.  As in 
the parent version, the BASC-TRS has three different versions that take into account the different 
developmental issues between age groups.  There is a preschool version (2-5 years old), child 
version (6-11 years old) and an adolescent version (12-18 years old).  
 
3.2.6 Pediatric Medical History Questionnaire  
 
 This measure contains a number of items concerning the child and mother’s medical 
history.  It inquires about the mother’s pregnancy and any history of mental disorders in the 
family.  The questionnaire also asks about the child’s medical history and any medication or 
behavioral treatment utilized.  In the current study, this measure will be used in determining any 
treatment received by the children.  The parent as asked to respond to a question asking about 
what type of treatment the child has received in the past for ADHD.  The options for this item are 
no treatment, psychosocial treatment, treatment with medication or combined treatment.   
3.3 Procedure  
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 In the previously collected data set, participants were diagnosed with ADHD by the 
primary clinician collecting the research.  The results of the measures as well as the clinician’s 
judgment were utilized in making this diagnosis.  In the current analysis, the DICA-R-P and the 
ADHD Rating Scale-IV Teacher version were used in making a diagnosis.    
 The criteria for diagnosing ADHD inattentive subtype were the parent report on the 
DICA-R-P met criteria for ADHD inattentive type and ratings on the ADHD Rating Scale-IV 
Teacher Version were at or above the 85th percentile on the Inattentive factors.  The criteria for 
diagnosing ADHD combined subtype were a parent report on the DICA-R-P met criteria for 
ADHD hyperactivity/impulsivity as well as inattention and ratings on the ADHD Rating Scale-IV 
Teacher Version were at or above the 85th percentile on both the hyperactivity/impulsivity factors 
and the inattentive factors.     
 The participants were determined to not have a diagnosis of ADHD if they did not meet 
DICA-R-P criteria for any ADHD subtype, and were not at or above the 85th percentile on the 
ADHD Rating Scales.   
The type of treatment utilized is an item on the pediatric and medical history 
questionnaire completed by the parents concerning the medical history of the children.  This 
questionnaire also contains questions concerning the general medical history of the participant 
and any family history of mental disorders.  
Participants were broken up into three age groups in considering the relationship between 
age, subtype and treatment.  The age groups were: 5-7 years, 8-10 years and 11-13 year olds.  
Participants were broken up in this manner in accordance with their status in school.  Five to 7 
year olds are just starting school (kindergarten to first or second grade), 8 to 10 year olds are at 
the mid to late elementary level (third to fifth grades) and 11 to 13 year olds are in late 
elementary to middle school.  These groups represent different levels of schooling that represent 
different concerns for children with ADHD.     
The current study considered the relationship between ADHD combined type, ADHD 
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and ADHD inattentive type in terms of treatment.  It is hypothesized that children diagnosed with 
ADHD combined type and hyperactive/impulsive type will receive more treatment with 
medication than psychosocial treatment and treatment will decrease with age in accordance with 
the waning of hyperactive symptoms. The use of psychosocial treatment will also decrease in 
following the symptoms of hyperactivity.    
 
3.4 Statistical Analysis  
 
3.4.1 Descriptive Statistics 
 Preliminary statistical analyses included descriptive statistics.  Descriptives will be 
utilized to give general information concerning the gender, and subtype break up of the 
participants in the data set.  Descriptives will also be used to determine the most commonly 
utilized treatment overall by participants in the data set.  
 
3.4.2 Multinomial Logistic Regression 
 A Multinomial Logistic Regression was analyzed to consider the treatment choices in 
terms of subtype, age and gender. The outcome variable is the type of treatment utilized 
(medication, psychosocial, both psychosocial and medication or no treatment) and the 
independent variables are gender (male or female), subtype (Hyperactive, inattentive or 
combined) and age (5-7, 8-10, 11-13).   
3.4.3 Crosstabulation 
 A crosstabulation was analyzed to consider the relationship between age, subtype and 
treatment utilization.  This allowed for a further understanding of the precise break up of 
participants between subtype age and treatment utilization as the number of participants within 
each group and interaction group was easily seen by looking at the size of each cell.  
Crosstabulations were used instead of a chi-square as the cell sized in the sample were not large 
enough to allow for a chi-square.  
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4. Results 
 
The current sample consisted of 336 males and 97 females.  Statistics revealed that of the four 
treatment categories (No treatment, treatment with stimulants, psychosocial treatment and 
treatment with medication and psychosocial), 70.7 percent of participants received no treatment, 
11.5 percent received treatment with stimulants, 9.5 percent received psychosocial treatment and 
8.3 percent received medication and psychosocial treatment.  Thirty-seven point 2 percent of 
participants fell between the ages of 5 and 7 years, 44.3 percent were between the ages of 8 and 
10 years and 18.5 percent were between 11 and 13 years old.  The majority of participants 
(47.8%) were diagnosed with ADHD Combined subtype using the DICA and ADHD Rating 
scale.  Twenty-three point eight percent had no diagnosis using these criteria and 28.4 percent 
were diagnosed with ADHD predominantly inattentive subtype.  The break up can be seen in 
table 1. 
 
Table 1 
 
Descriptive Statistics   
   
Variable Subjects Percentages 
No Treatment 306 70.7% 
Treatment with Stimulants 50 11.5% 
Psychosocial Treatment 41 9.5% 
Treatment with medication and psychosocial 36 8.3% 
5 to 7 years old 161 37.2% 
8 to 10 years old 192 44.3% 
11 to 13 years old 80 18.5% 
No Diagnosis 103 23.8% 
Diagnosis of Combined Type 207 47.8% 
Diagnosis of Inattentive Type 123 28.4% 
Male 336 77.6% 
Female 97 22.4% 
 
 
 A multinomial logistic regression was utilized in analyzing the data.  The “No 
Treatment” group was used as a reference as it allowed each independent variable to be 
considered in terms of the likelihood that they will receive no treatment verse treatment with 
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stimulants, psychosocial treatment and multimodal treatment.  The Psuedo R-squared value, 
Nagelkerke is .138, indicating that 13.8% of the variance in treatment utilization can be 
accounted for by these predictors.  The likelihood ratio tests indicate that Diagnosis is a 
significant predictor of treatment utilization (p = .000).  Age is also a significant predictor of 
treatment utilization (p = .001).   
A significant relationship was found between age and treatment utilization.  Parameter 
estimates indicate that participants between the ages of 5 and 7 years were more likely to have 
received no treatment than to have received multimodal treatment (p = .000).  Subjects between 
the ages of 8 and 10 years were also significantly more likely to receive no treatment than to have 
received treatment with stimulants (p = .011).  Subjects diagnosed with ADHD combined type 
were more likely to have received no treatment than to have received treatment with stimulants (p 
= .033).  Participants diagnosed with ADHD Combined subtype were also significantly more 
likely to have received no treatment than to have received multimodal treatment.     
In order to examine the interaction between age, diagnosis and treatment utilization, cross 
tabulations were conducted to more specifically look at the break up of the sample.  A 
crosstabulations was considered instead of a chi-square because the cell sizes were too small to 
allow for a chi-square analysis.  The numbers reported from the crosstabulation and therefore the 
graphs, are the number of participants within each group and not the percentage of participants. 
Of the participants that had not received any treatment, the majority were between the ages of 5 
and 7 years and were diagnosed with ADHD combined subtype.  In total, 126 children between 
the ages of 5 and 7 years had not received any treatment.  This total number decreased with age as 
49 subjects between the ages of 11 and 13 had not received any type of treatment.  However, 
within the inattentive subtype, the number of subjects that had received no treatment increased 
from 18 (14.3%) in 5 to 7 year olds to 45 (34.4%) in 8 to 10 year olds then decreased to 25 in the 
11 to 13 year old age group.   
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Of subjects being treated with stimulant medication the group with the largest total 
number of participants was children between the ages of 8 and 10 years.  Also, subjects diagnosed 
with ADHD combined type make up the majority of participants that receive treatment with 
stimulant medication.  Within the 5 to 7 year old age group, and the 8 to 10 year old age group, 
subjects with combined subtype make up the highest number of those receiving treatment with 
stimulant medication.  Participants between the ages of 11 and 13 years have very small cell sizes 
across diagnoses.  However, inattentive type represents the majority of those within this age 
group that receive treatment with stimulants.  The results are similar for subjects receiving only 
psychosocial treatment.  Subjects between the ages of 8 and 10 years old diagnosed with ADHD 
combined type make up the majority of participants receiving psychosocial treatment.  Five to 7 
year olds diagnosed with ADHD Combined type makes up the second largest group of 
participants receiving psychosocial treatment only.  Of those participants between the ages of 11 
and 13 years old, the majority of subjects receiving only psychosocial treatment were diagnosed 
with ADHD predominantly inattentive subtype.  However, the number of participants diagnosed 
with ADHD predominantly inattentive type receiving psychosocial treatment increased between 
the 5 to 7 year age group and the 8 to 10 year age group and then decreased between 8 to 10 years 
and 11 to 13 years.  The break up of participants can be seen below (in count).    
Figure 1 
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5. Discussion 
  
In the current analysis, it was hypothesized that participants diagnosed with ADHD 
combined type would receive more treatment with medication than psychosocial treatment and 
that treatment use would decrease with age in accordance with the waning of 
hyperactive/impulsive symptoms.  The results of the analysis did not support this hypothesis as 
the only significant relationship found was between no treatment, age and combined subtype.  
These results may be due to the overwhelmingly large number of participants receiving no 
treatment within the sample.  
 It was also hypothesized that participants diagnosed with ADHD Inattentive type would 
receive more psychosocial treatment and that treatment utilization would increase with age.  
These results were also not supported by the current analysis. The objective of the current 
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analysis was to consider whether age, subtype and gender were significant predictors of treatment 
utilization in children diagnosed with ADHD.  However, the analysis only found a significant 
relationship between age and no treatment and diagnosis and no treatment.  Limitations and 
possible explanations for these results are discussed below.    
 Limitations: 
 One limitation of the current analysis is that the data set utilized was a sample of 
convenience.  The participants were coming to the Children’s Hospital of Philadelphia for a 
psychological evaluation and therefore may have been seeking treatment.  Therefore, the data set 
was not conducive to the question being asked in the analysis as it only considered the type of 
treatment utilized prior to the evaluation.  Treatment after the evaluation was not considered 
when the participants may have very well received some type of treatment as a result of the 
evaluation. 
Another limitation of the current analysis is the uneven distribution of treatment 
utilization by the subjects in the data set.  The majority of participants have not utilized treatment 
in controlling the symptoms of ADHD.  It also is important to note that this is cross sectional data 
and is not longitudinal.  This may have some effect on the results of the analysis.   
The measure used in determining treatment utilization was a pediatric medical 
questionnaire developed by the researchers.  The measure did not have any psychometric 
properties and was reliant on the parent accurately answering all of the questions.  Clinicians did 
not have access to medical records to ensure the accuracy of the responses given by the child’s 
parent.   
 There was no significant relationship found between ADHD inattentive type and 
treatment utilization. There was also not a significant relationship between gender and treatment 
utilization as hypothesized.  It has been established that males and females with ADHD tend to 
present symptoms differently.  Therefore it was thought that they may receive different treatment.  
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The data set was overwhelmingly male (77.6%).   The findings may have been different if the 
subjects were more evenly split between males and females.  
One of the preliminary findings of this study is that the majority of the subjects 
considered received no treatment, regardless of age, subtype or gender.  This is particularly 
noteworthy in the 11 to 13 year old age groups as these children are further along in their 
schooling and may be struggling more with their symptoms.  However, it should be considered 
that participants may be seeking treatment at the time of the intake and therefore may have 
shortly after begun receiving treatment.  Within subjects diagnosed with ADHD Combined type, 
8 to 10 year olds make up the largest number of participants receiving multimodal treatment.  In 
support of the hypothesis, this number decreases in the 11 to 13 year old age group.  These 
findings are important in considering the trends in treatment utilization and support the 
hypothesis that treatment for children with hyperactive symptoms will decrease with age. 
However, these results should be considered with caution, as the number of participants in each 
cell of the crosstabulation was relatively small due to the break up of the subjects.   
 
6. Future Directions 
 
 Future studies should consider methods of identification and treatment of ADHD at an 
earlier age, as the majority of participants in the current analysis received no treatment.  This is 
particularly important in considering subjects in the 11 to 13 year old age group as not receiving 
treatment by this point (middle school and upper elementary school) may have detrimental effects 
on academic and social abilities. It may be beneficial to consider ways of detecting and treating 
ADHD at an earlier age, with the hope of earlier intervention and more positive outcome. 
 The fact that the majority of children in this sample diagnosed with ADHD combined 
type have not received any treatment is particularly concerning.  These children tend to be more 
externalizing and disruptive, leading one to believe that they would be identified and treated 
somewhat readily.  This may be due to a lack of awareness of the signs of ADHD or a lack of 
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awareness in how to proceed with a child that may display behavior problems.  It may be 
beneficial to consider why it is that these children have not received treatment and possibly 
attempt to increase awareness of treatment options as well as identification of ADHD.   
 Future research should also consider why there are not differences in treatment utilization 
in terms of gender.  If males and females tend to present symptoms differently, differences in 
treatment would make sense.  It would also be beneficial to consider the interaction between 
gender, age and diagnosis in predicting treatment utilization.  Lastly, other variables such as 
socioeconomic status and self-identified race may be useful to consider as predictors in and of 
themselves as well as how they interact with age, gender and diagnosis in predicting treatment 
utilization.   
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